GENE ONLINE|News &
Opinion
Blog

2020-06-10| PartnerAsia-Pacific

Nobel Laureate Dr. Honjo to Speak at BIO Asia–Taiwan 2020

by GeneOnline
Share To
 
 

Dr. Tasuku Honjo (本庶 佑), Distinguished Professor of Kyoto University, Japan, shared the 2018 Nobel Prize in Medicine or Physiology for his contributions to the immune checkpoint blockade approach in cancer immunotherapy. His discoveries have been responsible in saving thousands of lives.

We are honored to announce that Dr. Tasuku Honjo will join us at BIO Asia–Taiwan 2020 as a Plenary Speaker, with his presentation titled Future of
Cancer Immunotherapy
.

 
The Early Bird special ends this week! Don’t miss your chance to join thousands of bioindustry professionals from Asia and around the world at BIO Asia–Taiwan 2020 Online + Live!
BIO Asia-Taiwan 2020 Secretariat

register@taiwanbio.org.tw | www.bioasiataiwan.com | +886-2-7700-3883

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
2022-07-28
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
2022-07-28
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26
LATEST
Eli Lilly Breaks Records with $9B Total Investment in Indiana Weight-loss Drug Expansion
2024-05-27
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
EVENT
Scroll to Top